Researchers have demonstrated in an animal model that targeting a receptor in the blood-brain barrier called pregnane X receptor can reduce the accumulation of the beta-amyloid protein linked to Alzheimer's disease. "This study may provide the experimental basis for new strategies that can be used to treat Alzheimer's patients," a researcher said.

Related Summaries